Screener
Actuate Therapeutics, Inc. ACTU Q1 2026 earnings
Reported May 14, 2026 · Before market open
EPS-$0.24Miss by $0.01
EPS estimate-$0.23
Next report
Nov 12, 2026 (In 1 week)EPS estimate-$0.18
Versus estimates
Diluted EPS
FAQ
- When did Actuate Therapeutics, Inc. report Q1 2026 earnings?
- Actuate Therapeutics, Inc. (ACTU) reported Q1 2026 earnings on May 14, 2026 before market open.
- What were Actuate Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Actuate Therapeutics, Inc. reported eps of $-0.24 for Q1 2026.
- Did Actuate Therapeutics, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.23 by $0.01.
- How did Actuate Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 25.0% from $-0.32.
- Where can I find Actuate Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001683168-26-003684) and the 10-Q periodic report (0001683168-26-003909) directly on SEC EDGAR. The filing index links above go to sec.gov.
